In light of the agreement, the company together with various members of the updated buyer group are required to prepare updated filings with the United States Securities and Exchange Commission, including an amended transaction statement on schedule 13E-3
to be filed with the SEC by the company and certain filing persons in connection with the merger, and the exhibits to the transaction statement.
In connection with the proposed merger, the company has filed a transaction statement on Schedule 13E-3
, a preliminary proxy statement and related materials with the Securities and Exchange Commission, and expects to file an amendment to the Schedule 13E-3
and updated proxy materials with the SEC in a timely manner.
The plan has been approved by the Cimetrix board of directors and is fully disclosed in the SEC Schedule 13E-3
filing, which is available at www.sec.gov.
A Lexis search for companies filing Schedule 13E-3
to go private (go dark) in 2004 revealed that close to 40% cited the cost of compliance with federal securities laws.
In addition, certain participants in the proposed Transactions will prepare and mail to the Company's shareholders a Schedule 13E-3
transaction statement that will include the company's proxy statement.
This information amends the previously filed Schedule 13E-3
Transaction Statement by the group taking the company private through a short form merger.
The Company and certain other participants in the Transactions will prepare and file with the SEC a Schedule 13E-3
transaction statement, which will include a proxy statement of the Company.
Shenzhen-based pharmaceutical company Tongjitang Chinese Medicines Company (NYSE:TCM) revealed on Monday that it has filed a going-private transaction statement on Schedule 13E-3
with the US Securities and Exchange Commission (SEC) on the basis of the proposed merger agreement between the company and Fosun Industrial Co Ltd, Hanmax Investment Ltd and Tonsun International Company Ltd.
The company has filed with the US Securities and Exchange Commission (SEC) a Schedule 13E-3
transaction statement and a related preliminary redemption notice/transaction statement.
Making this announcement on Wednesday, the company said that it intends to file a Schedule 13E-3
with respect to the proposed offer with the US Securities and Exchange Commission and submit the necessary court filings to the Courts of the British Virgin Islands with respect to the proposed offer as soon as possible.
A group of stockholders controlling 91.1% of Digital Lightwave's outstanding shares filed a Schedule 13E-3
, concerning the merger, with the US Securities and Exchange Commission on Wednesday.
A preliminary proxy statement and Schedule 13E-3
will soon be filed with the US Securities and Exchange Commission (SEC) to initiate the reverse/forward stock split.